article thumbnail

Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy

Heart BMJ

Background High-intensity physical activity has traditionally been discouraged in patients with hypertrophic cardiomyopathy due to concerns about triggering sudden cardiac death. However, current guidelines adopt a more liberal stance, and evidence on risk factors for exercise-related sudden cardiac death remains limited.

article thumbnail

Heart Vest Could Help Predict Sudden Cardiac Death Risk

DAIC

Image courtesy of UCL Institute of Cardiovascular Science / James Tye milla1cf Tue, 12/19/2023 - 18:19 December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to better identify people at high risk of sudden cardiac death , suggests a new study led by UCL researchers.

article thumbnail

Rate and Cause of Sudden Cardiac Death in the Young During the COVID-19 Pandemic and Vaccination

Circulation

Circulation, Volume 148, Issue 25 , Page 2069-2071, December 19, 2023.

article thumbnail

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of?>?80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)

Cardiovascular Diabetology

Methods We searched in databases (PubMed, Embase, Cochrane Library, and clinicaltrials.gov) up to April 2023. RCTs comparing SGLT2i with placebo were included. Results 33 placebo-controlled RCTs were included, comprising 88,098 patients (48,585 in SGLT2i vs. 39,513 in placebo).

article thumbnail

HCM Research Explores SCD Risk Stratification, High Intensity Exercise, and Benefits of Valsartan

American College of Cardiology

Although the 2024 ACC/American Heart Association (AHA) and 2023 European Society of Cardiology (ESC) guidelines stratify well overall the risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM).

article thumbnail

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

DAIC

El-Hamamsy is a recognized expert in aortic surgery, including the Ross procedure, and led a team of Mount Sinai cardiovascular surgeons to perform more than 100 successful Ross procedures in 2023—the first time any surgical program in the world has achieved this milestone in a single year.

article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

Eventually, this causes the heart to weaken and function poorly, which may lead to heart failure and increased risk for sudden cardiac death. Abstract presented at: 37th Annual Meeting of the European Association for Cardio-Thoracic Surgery; October 4-7, 2023; Vienna, Austria. 11Sohn SH, Kang Y, Kim JS, et al.,